Animal Stem Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Report
410 Pages
December 2023
Region: Global
Fairfield Market Research
ID: 5913358

The global animal stem cell therapy market is on an upward trajectory, with a valuation of US$ 290 million in 2024. By the end of 2031, the market is expected to surge to approximately US$ 411 million, driven by a host of opportunities for manufacturers and key market players.

Opportunities Abound for Animal Stem Cell Therapy Product Manufacturers

Manufacturers of animal stem cell therapy products, particularly in developed countries, are poised to capitalize on a wave of attractive prospects in the coming years. Emerging markets also offer significant growth potential. Several key factors are driving this positive outlook:

Pet Humanization: The growing trend of pet humanization has led to pet owners demanding higher levels of veterinary care, creating a positive demand for animal stem cell therapy.
Increased Pet Adoptions: Rising pet adoption rates, especially in Western countries, have bolstered the demand for high-quality care for animals, including dogs, cats, and horses.
Research and Development: Ongoing research and development activities provide manufacturers with attractive opportunities to expand their presence and offerings in the animal stem cell therapy domain.

Challenges Confronting Animal Stem Cell Therapy

Despite the promising growth prospects, the animal stem cell therapy market faces certain hurdles:

High Treatment Costs: The relatively high cost of animal stem cell therapy procedures makes some pet owners hesitant to invest in their pet's treatment.
Limited Availability: Many standard veterinary hospitals lack the resources to provide stem cell therapy to animals, limiting accessibility.
Pet Insurance Coverage: While some pet insurance companies cover the cost of stem cell therapy, they often do not cover follow-up treatments, and a significant number of pet owners do not have pet insurance plans.

Country-wise Insights

U.S. Market Attraction: The United States is a target market for animal stem cell therapy providers due to increased pet adoption rates and the growing demand for high-quality pet care.

Germany's Key Role: Germany boasts a high market share percentage, thanks to the presence of numerous key players, enhancing product availability.

Australia's Prominence: Australia emerges as a prominent market, driven by a higher prevalence of degenerative joint diseases in animals, particularly osteoarthritis in dogs.

India's Growing Potential: India is showing increasing interest in animal welfare and higher spending on animal healthcare, offering opportunities for industry players to expand their services and product portfolios.

Competitive Landscape

The animal stem cell therapy market is moderately fragmented, featuring well-established players. Intense competition drives market players to actively seek collaboration for new product development, expanding their product outreach.

Key Companies Profiled

Aratana Therapeutics, Inc.
VetStem, Inc.
Regeneus Ltd.
Magellan Stem Cells
PrimeGen Biotech, LLC
Vetbiologics (U.S. Stem Cell, Inc.)
Boehringer Ingelheim (Global stem cell technology)
Cell Therapy Sciences
VETherapy Corporation
MediVet Biologics LLC (Ardent Animal Health)
Animal Cell Therapies, Inc.
Medrego
AniCell Biotech

Key Segments Covered in Animal Stem Cell Therapy Industry Research

Animal Stem Cell Therapy Market by Product Type:

Hemopoietic Stem Cells
Mesenchymal Stem Cells

Animal Stem Cell Therapy Market by Source:

Allogeneic Animal Stem Cell Therapy
Autologous Animal Stem Cell Therapy

Animal Stem Cell Therapy Market by Application:

Osteoarthritis
Soft Tissue Injuries
Traumatic Fractures
Tendonitis
Inflammatory Bowel Disease
Others

Animal Stem Cell Therapy Market by Species:

Canine
Feline
Equine

Animal Stem Cell Therapy Market by End User:

Veterinary Hospitals
Veterinary Clinics
Veterinary Research Institutes

Animal Stem Cell Therapy Market by Region:

North America Animal Stem Cell Therapy Market
Latin America Animal Stem Cell Therapy Market
Europe Animal Stem Cell Therapy Market
South Asia Animal Stem Cell Therapy Market
East Asia Animal Stem Cell Therapy Market
Oceania Animal Stem Cell Therapy Market
Middle East & Africa Animal Stem Cell Therapy Market

This product will be delivered within 1-3 business days.

1. Executive Summary

1.1. Global Animal Stem Cell Therapy Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Animal Stem Cell Therapy Market Outlook, 2018 - 2031

3.1. Global Animal Stem Cell Therapy Market Outlook, by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Hemopoietic Stem Cells
3.1.1.2. Mesenchymal Stem Cells
3.2. Global Animal Stem Cell Therapy Market Outlook, by Source, Value (US$ Mn) and Volume, 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Allogeneic Animal Stem Cell Therapy
3.2.1.2. Autologous Animal Stem Cell Therapy
3.3. Global Animal Stem Cell Therapy Market Outlook, by Application, Value (US$ Mn) and Volume, 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Osteoarthritis
3.3.1.2. Soft Tissue Injuries
3.3.1.3. Traumatic Fractures
3.3.1.4. Tendonitis
3.3.1.5. Inflammatory Bowel Disease
3.3.1.6. Others
3.4. Global Animal Stem Cell Therapy Market Outlook, by Species, Value (US$ Mn) and Volume, 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Canine
3.4.1.2. Feline
3.4.1.3. Equine
3.5. Global Animal Stem Cell Therapy Market Outlook, by End Use, Value (US$ Mn) and Volume, 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. Veterinary Hospitals
3.5.1.2. Veterinary Clinics
3.5.1.3. Veterinary Research Institutes
3.6. Global Animal Stem Cell Therapy Market Outlook, by Region, Value (US$ Mn) and Volume, 2018 - 2031
3.6.1. Key Highlights
3.6.1.1. North America
3.6.1.2. Europe
3.6.1.3. Asia Pacific
3.6.1.4. Latin America
3.6.1.5. Middle East & Africa

4. North America Animal Stem Cell Therapy Market Outlook, 2018 - 2031

4.1. North America Animal Stem Cell Therapy Market Outlook, by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Hemopoietic Stem Cells
4.1.1.2. Mesenchymal Stem Cells
4.2. North America Animal Stem Cell Therapy Market Outlook, by Source, Value (US$ Mn) and Volume, 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Allogeneic Animal Stem Cell Therapy
4.2.1.2. Autologous Animal Stem Cell Therapy
4.3. North America Animal Stem Cell Therapy Market Outlook, by Application, Value (US$ Mn) and Volume, 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Osteoarthritis
4.3.1.2. Soft Tissue Injuries
4.3.1.3. Traumatic Fractures
4.3.1.4. Tendonitis
4.3.1.5. Inflammatory Bowel Disease
4.3.1.6. Others
4.4. North America Animal Stem Cell Therapy Market Outlook, by Species, Value (US$ Mn) and Volume, 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Canine
4.4.1.2. Feline
4.4.1.3. Equine
4.5. North America Animal Stem Cell Therapy Market Outlook, by End Use, Value (US$ Mn) and Volume, 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. Veterinary Hospitals
4.5.1.2. Veterinary Clinics
4.5.1.3. Veterinary Research Institutes
4.5.2. BPS Analysis/Market Attractiveness Analysis
4.6. North America Animal Stem Cell Therapy Market Outlook, by Country, Value (US$ Mn) and Volume, 2018 - 2031
4.6.1. Key Highlights
4.6.1.1. U.S. Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
4.6.1.2. U.S. Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
4.6.1.3. U.S. Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
4.6.1.4. U.S. Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
4.6.1.5. U.S. Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
4.6.1.6. Canada Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
4.6.1.7. Canada Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
4.6.1.8. Canada Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
4.6.1.9. Canada Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
4.6.1.10. Canada Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
4.6.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Animal Stem Cell Therapy Market Outlook, 2018 - 2031

5.1. Europe Animal Stem Cell Therapy Market Outlook, by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Hemopoietic Stem Cells
5.1.1.2. Mesenchymal Stem Cells
5.2. Europe Animal Stem Cell Therapy Market Outlook, by Source, Value (US$ Mn) and Volume, 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Allogeneic Animal Stem Cell Therapy
5.2.1.2. Autologous Animal Stem Cell Therapy
5.3. Europe Animal Stem Cell Therapy Market Outlook, by Application, Value (US$ Mn) and Volume, 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Osteoarthritis
5.3.1.2. Soft Tissue Injuries
5.3.1.3. Traumatic Fractures
5.3.1.4. Tendonitis
5.3.1.5. Inflammatory Bowel Disease
5.3.1.6. Others
5.4. Europe Animal Stem Cell Therapy Market Outlook, by Species, Value (US$ Mn) and Volume, 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Canine
5.4.1.2. Feline
5.4.1.3. Equine
5.5. Europe Animal Stem Cell Therapy Market Outlook, by End Use, Value (US$ Mn) and Volume, 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. Veterinary Hospitals
5.5.1.2. Veterinary Clinics
5.5.1.3. Veterinary Research Institutes
5.5.2. BPS Analysis/Market Attractiveness Analysis
5.6. Europe Animal Stem Cell Therapy Market Outlook, by Country, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1. Key Highlights
5.6.1.1. Germany Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.2. Germany Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.3. Germany Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.4. Germany Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.5. Germany Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.6. U.K. Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.7. U.K. Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.8. U.K. Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.9. U.K. Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.10. U.K. Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.11. France Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.12. France Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.13. France Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.14. France Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.15. France Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.16. Italy Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.17. Italy Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.18. Italy Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.19. Italy Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.20. Italy Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.21. Turkey Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.22. Turkey Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.23. Turkey Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.24. Turkey Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.25. Turkey Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.26. Russia Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.27. Russia Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.28. Russia Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.29. Russia Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.30. Russia Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.31. Rest of Europe Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.32. Rest of Europe Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.33. Rest of Europe Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.34. Rest of Europe Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
5.6.1.35. Rest of Europe Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
5.6.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Animal Stem Cell Therapy Market Outlook, 2018 - 2031

6.1. Asia Pacific Animal Stem Cell Therapy Market Outlook, by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Hemopoietic Stem Cells
6.1.1.2. Mesenchymal Stem Cells
6.2. Asia Pacific Animal Stem Cell Therapy Market Outlook, by Source, Value (US$ Mn) and Volume, 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Allogeneic Animal Stem Cell Therapy
6.2.1.2. Autologous Animal Stem Cell Therapy
6.3. Asia Pacific Animal Stem Cell Therapy Market Outlook, by Application, Value (US$ Mn) and Volume, 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Osteoarthritis
6.3.1.2. Soft Tissue Injuries
6.3.1.3. Traumatic Fractures
6.3.1.4. Tendonitis
6.3.1.5. Inflammatory Bowel Disease
6.3.1.6. Others
6.4. Asia Pacific Animal Stem Cell Therapy Market Outlook, by Species, Value (US$ Mn) and Volume, 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Canine
6.4.1.2. Feline
6.4.1.3. Equine
6.5. Asia Pacific Animal Stem Cell Therapy Market Outlook, by End Use, Value (US$ Mn) and Volume, 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. Veterinary Hospitals
6.5.1.2. Veterinary Clinics
6.5.1.3. Veterinary Research Institutes
6.5.2. BPS Analysis/Market Attractiveness Analysis
6.6. Asia Pacific Animal Stem Cell Therapy Market Outlook, by Country, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1. Key Highlights
6.6.1.1. China Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.2. China Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.3. China Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.4. China Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.5. China Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.6. Japan Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.7. Japan Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.8. Japan Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.9. Japan Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.10. Japan Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.11. South Korea Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.12. South Korea Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.13. South Korea Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.14. South Korea Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.15. South Korea Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.16. India Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.17. India Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.18. India Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.19. India Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.20. India Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.21. Southeast Asia Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.22. Southeast Asia Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.23. Southeast Asia Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.24. Southeast Asia Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.25. Southeast Asia Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.26. Rest of Asia Pacific Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.27. Rest of Asia Pacific Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.28. Rest of Asia Pacific Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.29. Rest of Asia Pacific Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
6.6.1.30. Rest of Asia Pacific Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
6.6.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Animal Stem Cell Therapy Market Outlook, 2018 - 2031

7.1. Latin America Animal Stem Cell Therapy Market Outlook, by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Hemopoietic Stem Cells
7.1.1.2. Mesenchymal Stem Cells
7.2. Latin America Animal Stem Cell Therapy Market Outlook, by Source, Value (US$ Mn) and Volume, 2018 - 2031
7.2.1.1. Allogeneic Animal Stem Cell Therapy
7.2.1.2. Autologous Animal Stem Cell Therapy
7.3. Latin America Animal Stem Cell Therapy Market Outlook, by Application, Value (US$ Mn) and Volume, 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Osteoarthritis
7.3.1.2. Soft Tissue Injuries
7.3.1.3. Traumatic Fractures
7.3.1.4. Tendonitis
7.3.1.5. Inflammatory Bowel Disease
7.3.1.6. Others
7.4. Latin America Animal Stem Cell Therapy Market Outlook, by Species, Value (US$ Mn) and Volume, 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Canine
7.4.1.2. Feline
7.4.1.3. Equine
7.5. Latin America Animal Stem Cell Therapy Market Outlook, by End Use, Value (US$ Mn) and Volume, 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Veterinary Hospitals
7.5.1.2. Veterinary Clinics
7.5.1.3. Veterinary Research Institutes
7.5.2. BPS Analysis/Market Attractiveness Analysis
7.6. Latin America Animal Stem Cell Therapy Market Outlook, by Country, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1. Key Highlights
7.6.1.1. Brazil Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1.2. Brazil Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1.3. Brazil Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1.4. Brazil Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1.5. Brazil Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1.6. Mexico Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1.7. Mexico Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1.8. Mexico Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1.9. Mexico Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1.10. Mexico Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1.11. Argentina Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1.12. Argentina Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1.13. Argentina Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1.14. Argentina Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1.15. Argentina Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1.16. Rest of Latin America Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1.17. Rest of Latin America Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1.18. Rest of Latin America Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1.19. Rest of Latin America Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
7.6.1.20. Rest of Latin America Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
7.6.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Animal Stem Cell Therapy Market Outlook, 2018 - 2031

8.1. Middle East & Africa Animal Stem Cell Therapy Market Outlook, by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Hemopoietic Stem Cells
8.1.1.2. Mesenchymal Stem Cells
8.2. Middle East & Africa Animal Stem Cell Therapy Market Outlook, by Source, Value (US$ Mn) and Volume, 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Allogeneic Animal Stem Cell Therapy
8.2.1.2. Autologous Animal Stem Cell Therapy
8.3. Middle East & Africa Animal Stem Cell Therapy Market Outlook, by Application, Value (US$ Mn) and Volume, 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Osteoarthritis
8.3.1.2. Soft Tissue Injuries
8.3.1.3. Traumatic Fractures
8.3.1.4. Tendonitis
8.3.1.5. Inflammatory Bowel Disease
8.3.1.6. Others
8.4. Middle East & Africa Animal Stem Cell Therapy Market Outlook, by Species, Value (US$ Mn) and Volume, 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Canine
8.4.1.2. Feline
8.4.1.3. Equine
8.5. Middle East & Africa Animal Stem Cell Therapy Market Outlook, by End Use, Value (US$ Mn) and Volume, 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. Veterinary Hospitals
8.5.1.2. Veterinary Clinics
8.5.1.3. Veterinary Research Institutes
8.5.2. BPS Analysis/Market Attractiveness Analysis
8.6. Middle East & Africa Animal Stem Cell Therapy Market Outlook, by Country, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1. Key Highlights
8.6.1.1. GCC Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.2. GCC Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.3. GCC Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.4. GCC Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.5. GCC Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.6. South Africa Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.7. South Africa Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.8. South Africa Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.9. South Africa Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.10. South Africa Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.11. Egypt Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.12. Egypt Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.13. Egypt Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.14. Egypt Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.15. Egypt Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.16. Nigeria Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.17. Nigeria Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.18. Nigeria Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.19. Nigeria Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.20. Nigeria Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.21. Rest of Middle East & Africa Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.22. Rest of Middle East & Africa Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.23. Rest of Middle East & Africa Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.24. Rest of Middle East & Africa Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2018 - 2031
8.6.1.25. Rest of Middle East & Africa Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2018 - 2031
8.6.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. By Species vs by Source Heat map
9.2. Manufacturer vs by Source Heat map
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Aratana Therapeutics, Inc.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. VetStem, Inc.
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Regeneus Ltd.
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Magellan Stem Cells
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. PrimeGen Biotech, LLC
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Vetbiologics (U.S. Stem Cell, Inc.)
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Boehringer Ingelheim (Global stem cell technology)
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Cell Therapy Sciences
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. MediVet Biologics LLC (Ardent Animal Health)
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Animal Cell Therapies, Inc
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Medrego
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. AniCell Biotech
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. VETherapy Corporation
9.5.13.1. Company Overview
9.5.13.2. Product Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Aratana Therapeutics, Inc.
VetStem, Inc.
Regeneus Ltd.
Magellan Stem Cells
PrimeGen Biotech, LLC
Vetbiologics (.U.S. Stem Cell, Inc.)
Boehringer Ingelheim (Global stem cell technology)
Cell Therapy Sciences
MediVet Biologics LLC (Ardent Animal Health)
Animal Cell Therapies, Inc
Medrego
AniCell Biotech
VETherapy Corporation

Methodology

LOADING...

Opportunities Abound for Animal Stem Cell Therapy Product Manufacturers

Manufacturers of animal stem cell therapy products, particularly in developed countries, are poised to capitalize on a wave of attractive prospects in the coming years. Emerging markets also offer significant growth potential. Several key factors are driving this positive outlook:

Challenges Confronting Animal Stem Cell Therapy

Despite the promising growth prospects, the animal stem cell therapy market faces certain hurdles:

Country-wise Insights

Competitive Landscape

Key Companies Profiled

Key Segments Covered in Animal Stem Cell Therapy Industry Research

Animal Stem Cell Therapy Market by Product Type:

Animal Stem Cell Therapy Market by Source:

Animal Stem Cell Therapy Market by Application:

Animal Stem Cell Therapy Market by Species:

Animal Stem Cell Therapy Market by End User:

Animal Stem Cell Therapy Market by Region:

Table of Contents

Companies Mentioned (Partial List)

Methodology

Related Topics

Related Reports

Animal Stem Cell Therapy Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Animal Stem Cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

Global Stem Cell Therapy Market Report and Forecast 2023-2031

Stem Cell Therapy for Multiple Sclerosis Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Stem Cell Therapy Global Market Report 2024